Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris

  • STATUS
    Not Recruiting
  • participants needed
    755
  • sponsor
    Aleor Dermaceuticals Limited
Updated on 22 January 2021
adapalene
cyst
acne medication
adapalene topical gel
mastocytosis
rosacea
differin
seborrheic dermatitis
psoriasis

Summary

To evaluate the therapeutic equivalence and safety of Adapalene Gel 0.3% (Aleor Dermaceuticals Limited, India) and Differin (Adapalene) Gel 0.3% (Galderma Laboratories, LP USA) in the treatment of acne vulgaris.

Details
Condition Acne Vulgaris
Treatment Adapalene Gel 0.3%, Differin 0.3% Topical Gel, Adapalene Gel 0.3% Vehicle Placebo
Clinical Study IdentifierNCT03650361
SponsorAleor Dermaceuticals Limited
Last Modified on22 January 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note